We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Input on Communicating Drug-Drug Interaction Information
FDA Seeks Input on Communicating Drug-Drug Interaction Information
July 19, 2013
As part of a continuing effort to address drug-drug interactions, the FDA’s Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will hold a meeting Sept. 25 to discuss strategies for the evaluation, interpretation and communication of drug-drug interaction (DDI) information.